Quantcast

Latest Lupus Stories

2014-03-27 12:27:48

New England Patriots defensive back Tavon Wilson serves as Walk Ambassador WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality Nick Cannon will serve as the Grand Marshal at the Walk to End Lupus Now(TM) event in Washington, D.C. on Saturday, April 19. Cannon will cut the opening ceremony ribbon and lead the more 4,000 walkers down Pennsylvania Avenue towards the Capitol, shedding light on the cruel mystery that is lupus....

2014-03-25 08:29:48

HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced the appointment of Daniel J. Wallace, MD and Murray Urowitz, MD, two experts in rheumatology, as consultants for the planned Phase II trial for the Company's hCDR1...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-12 20:24:20

HAYWARD, Calif., March 12, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended December 31, 2013. Fourth Quarter and Fiscal Year 2013 Financial Results: Net loss for the fourth quarter and year ended December 31, 2013 was $9.2 million and $30.9 million, respectively. Operating expense for the year ended December 31, 2013 was $28.2 million as compared to $55.9 million for...

2014-03-11 23:33:04

Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with systemic lupus erythematosus (SLE). Birmingham, Alabama (PRWEB) March 11, 2014 *To see if you qualify for this Lupus Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no...

2014-02-04 16:29:30

Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb. 4, 2014 /PRNewswire/ -- The Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) are proud to join the National Institutes of Health (NIH) in the Accelerating Medicines Partnership (AMP) launched today to speed new paths to treatment for lupus and autoimmune diseases. The new $230 million collaboration will harness the collective knowledge and resources...

2014-02-04 12:27:31

Lupus Foundation of America Joins a Five-Year Initiative to Bring Together Government, Academia, Industry and Nonprofit Health Organizations to Harness Capabilities and Resources WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases....

2014-01-30 08:30:46

LOS ANGELES, Jan. 30, 2014 /PRNewswire/ -- Lupus LA and Cedars-Sinai Medical Center have joined together to support a two-year fellowship and have named Dr. Vaneet Sandhu as the Lupus LA/Cedars-Sinai Fellow. Lupus is a chronic autoimmune disease that can affect virtually any organ of the body, and has no known cause or cure. Dr. Sandhu will be joining a 'dream team' of lupus researchers at Cedars-Sinai, known in the medical community for cutting edge research and world-renowned...

2014-01-29 23:32:21

Health and Harmony LLC now offers a natural way to increase the immune system, gain added protection against the flu, and offset the unwanted side effects that so many prescription drugs can cause with a natural, nonaddictive immune booster created by world-renowned immunologist Dr. Yasuhiko Kojima. Peoria, IL (PRWEB) January 29, 2014 Health and Harmony LLC now offers a natural way to increase the immune system, gain added protection against the flu, and offset the unwanted side effects...

2014-01-23 12:29:25

New LIFELINE Grant Will Help Sustain Lupus Research That's at the Brink of Breakthrough WASHINGTON, Jan. 23, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today it is accepting applications to provide critical funding for lupus scientific research, at a time when government funds for lupus research can't keep pace with the accelerating growth of lupus scientific opportunities. The new LIFELINE Grant Program will provide research funds to help mitigate...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related